Phase 2 Ketamine Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more

National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908

Recruiting

Phase 2

Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients

Depression DisorderKetamine

Hospital Italiano de Buenos Aires50 enrolled2 locationsNCT07639359

Recruiting

Phase 2

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Pain ManagementSickle Cell DiseaseVaso-Occlusive Crises+2 more

Mohsen Saidinejad120 enrolled1 locationNCT07369024